Mythili Kameswaran

Employment

Employment history is unavailable.

Education

• Bhabha Atomic Research Centre PhD
  1990 - 1995
• University of Mumbai MSc
  1979 - 1981

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Induction of different cellular arrest and molecular responses in low EGFR expressing A549 and high EGFR expressing A431 tumor cells treated with various doses of 177Lu-Nimotuzumab
  International Journal of Radiation Biology 2020 DOI: 10.1080/09553002.2020.1793012
  +Save
• Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab')2 and F(ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphoma
  Applied Radiation and Isotopes 2019 DOI: 10.1016/j.apradiso.2019.108808
  +Save
• Preparation and preliminary bioevaluation studies of 68Ga‐NOTA‐rituximab fragments as radioimmunoscintigraphic agents for non‐Hodgkin lymphoma
  Journal of Labelled Compounds and Radiopharmaceuticals 2019 DOI: 10.1002/jlcr.3803
  +Save
• Preparation of 177Lu‐labeled Nimotuzumab for radioimmunotherapy of EGFR‐positive cancers: Comparison of DOTA and CHX‐A″‐DTPA as bifunctional chelators
  Journal of Labelled Compounds and Radiopharmaceuticals 2019 DOI: 10.1002/jlcr.3707
  +Save
• Ready-to-use 177Lu-Rituximab injection for Non-Hodgkin’s Lymphoma: Formulation and preliminary clinical study
  Journal of Radioanalytical and Nuclear Chemistry 2018 DOI: 10.1007/s10967-018-6042-7
  +Save
• 68Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors
  Bioorganic & Medicinal Chemistry Letters 2017 DOI: 10.1016/j.bmcl.2017.08.065
  +Save